Dynamic changes and clinical significance of serum tryptase levels in STEMI patients treated with primary PCI.
To investigate the dynamic changes in serum tryptase levels and their association with clinical data in patients with acute ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). Serum tryptase levels were measured in 99 STEMI patients and 25 control subjects. Tryptase levels were significantly increased at admission, and descended after primary PCI. Tryptase levels at 0.5, 2 and 6 h after PCI were negatively correlated with the percentage of ST-segment resolution (STR) as well as left ventricular ejection fraction (LVEF). High tryptase levels after PCI were associated with poor myocardial reperfusion and poor cardiac function.